Newsletter Subject

Only One Harm From mRNA COVID Vaccines, Report Determines

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Apr 20, 2024 11:16 AM

Email Preheader Text

Weekly Review Saturday, April 20, 2024 THE BREAK ROOM CME SPOTLIGHT THE BREAK ROOM ADVERTISEMENT CME

[MEDPAGE TODAY]( Weekly Review Saturday, April 20, 2024 [Only One Harm From mRNA COVID Vaccines, Report Determines]( [Monica Bertagnolli: U.S. 'Ready' for Next Pandemic Threat]( [I'm an Autistic Doctor. Here's How to Improve Care for Autistic Patients.]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Optimizing Treatment With Infusion-Based Therapies for HR+/HER2- and Triple-Negative Breast Cancer]( [NEJM Begins Limiting Access for Certain News Organizations]( [The H5N1 Outbreak Is Not a Test Run, It's a Warning Shot]( THE BREAK ROOM [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT ['Satanic Panic' Psychiatrist Dies; Caplyta Depression Win; Esketamine After Birth]( CME SPOTLIGHT [Optimizing the Management of Patients With mCRPC in Rural Communities: A Project ECHO Initiative]( [Ortiz Victim Speaks Out; Collapsed Imaging Table Suit; Hospital Exec Embezzled $600K]( [EDs Refused to Treat Pregnant Women, Leaving One to Miscarry in a Lobby Restroom]( [Could Francis Collins's Prostate Cancer Story Deter Men From Active Surveillance?]( CME SPOTLIGHT [The Future of NSCLC Care: Leveraging Biomarker Testing in the Management of Early-Stage, Resectable Disease]( [High Lipoprotein(a) Levels' Hit on Heart Health Doesn't Discriminate]( [Mucinex Pregnancy? Boston Marathon Runner's Diarrhea; Probiotic Hot Takes]( [Antipsychotics in Dementia Tied to Wider Range of 'Serious Harms']( CME SPOTLIGHT [Moving the Needle: Adopting New Evidence Into the Lower-Risk Myelodysplastic Syndrome Treatment Paradigm]( [Should DOs and MDs Have Separate Licensing Boards? They Still Do in 13 States]( [Deeper Sedation During Colonoscopy Linked to Improved Detection of Serrated Polyps]( [Nepali Plaintiffs Double Down on 'Severe Harm' Caused by Invalidated USMLE Scores]( CME SPOTLIGHT [Improving Real-World Care For Veteran Patients With Hepatocellular Carcinoma: Strategies for Patient-Centered, Teams-Based Approaches]( [Doctors Strike at Detroit Hospital After Unionizing Last Year]( [It's the First Drug Shown to Slow Alzheimer's. Why Is It Off to a Slow Start?]( [Brenzavvy vs Farxiga for T2D; PFAS in Seafood; 100 Deaths Linked to GLP-1 Drugs?]( CME SPOTLIGHT [Novel and Emerging Evidence in Early-Stage Breast Cancer]( [FDA Slaps Embolization Device With Class I Recall After Deaths]( [The California Saga: Why Some DOs Fear Combined Medical Boards]( [FDA Advisors' COIs; Ongoing Ukraine Heart Transplants; N.J. Cardiologist's $2M Fraud]( CME SPOTLIGHT [Latest Clinical Evidence in Adult Diffuse Low-Grade Glioma]( [Don't Rule Out Breast Cancer Surgery for 90-Year-Olds]( [Urine Test Accurately Detected High-Grade Prostate Cancer]( ['A Pain in the Ass': What We Heard This Week]( CME SPOTLIGHT [Applying the Latest Clinical Evidence to Treatment Plans for Pediatric Patients With Hodgkin Lymphoma]( [Federal Probes Need to Look Beyond Private Equity-Owned Healthcare for Alleged Abuse]( [Congress Can Take Action to Prevent Older Adult Falls and Associated Opioid Use]( [Growing Eye Mass Leads to a Rare Diagnosis]( [Delirium and Dementia; Are Biosimilars Cheaper for Patients?]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2024-04-20&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

26/05/2024

Sent On

26/05/2024

Sent On

25/05/2024

Sent On

24/05/2024

Sent On

24/05/2024

Sent On

24/05/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.